Our executive management team, under the direction of industry leader Paul V. Campanelli, combines many years of comprehensive pharmaceutical experience with operational, financial and legal expertise to position Endo for growth and success. The team has a shared commitment to lead to Endo to become a leading global specialty pharmaceutical company that improves patients’ lives and creates shareholder value.
Learn more about our Management Team
Our Board of Directors
The Board of Directors at Endo International plc is responsible for monitoring the operating performance and financial condition of the company, appointing the chief executive, overseeing the company's adherence to corporate governance standards, approving significant transactions, and establishing the strategic direction of the company.
The Board consists of eleven members and is led by Roger Kimmel.
Learn more about our Board of Directors